NCT05852691
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05852691
Title A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | ITA | ISR | HUN | ESP | DEU | CZE | BRA | AUS | ARG

Facility Status City State Zip Country Details
Cancer Blood and Specialty Clinic Los Alamitos California 90720 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Novant Health Presbyterain Medical Center Charlotte North Carolina 28204 United States Details
Novant Health Forsyth Medical Center Winston-Salem North Carolina 27103 United States Details
Avera Cancer Institute Sioux Falls South Dakota 57105 United States Details
Fundación CENIT para la Investigación en Neurociencias Buenos Aires C1125ABD Argentina Details
Sunshine Hospital St Albans Victoria Australia Details
Hospital Araujo Jorge Goiânia Goiás 74605-070 Brazil Details
Hospital do Cancer de Pernambuco - HCP Recife Pernambuco 50040-000 Brazil Details
Hospital de Cancer de Barretos Barretos São Paulo 14784-400 Brazil Details
Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda São Paulo São Paulo 01317-001 Brazil Details
Fakultni Thomayerova nemocnice Praha 4 - Krc 140 59 Czechia Details
Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH Essen 45136 Germany Details
Dres. Andreas Köhler und Roswitha Fuchs Langen 63225 Germany Details
Universitätsklinikum Ulm Am Michelsberg Ulm 89075 Germany Details
Komarom-Eszergom Varmegyei Szent Borbala Korhaz Tatabánya 2800 Hungary Details
Hadassah University Hospital - Ein Kerem Jerusaelm 9112001 Israel Details
Sheba Medical Center Ramat Gan 5262100 Israel Details
Ospedale Provinciale Santa Maria Delle Croci Ravenna Emilia-Romagna 48100 Italy Details
Ospedale San Raffaele Milan Lombardy 20132 Italy Details
Health Pharma Professional Research Mexico City Mexico CITY (federal District) 03100 Mexico Details
OncoMed Mexico City Mexico CITY (federal District) 03100 Mexico Details
Centro Médico Zambrano Hellion Monterrey Nuevo León 66278 Mexico Details
Centro de Investigacion Clinica de Oaxaca Oaxaca City Oaxaca 68020 Mexico Details
Centro Medico Monte Carmelo Arequipa 04001 Peru Details
Oncosalud Sac Lima 41 Peru Details
Instituto Nacional de Enfermedades Neoplasicas Lima Lima 34 Peru Details
Instituto Peruano de Oncología y Radioterapia Lima Peru Details
?wi?tokrzyskie Centrum Onkologii Kielce 25-734 Poland Details
Szpital Uniwersytecki w Krakowie, Oddzia? Kliniczny Kliniki Onkologii Krakow 31-501 Poland Details
Medical Oncology Centre of Rosebank Johannesburg 2196 South Africa Details
Seoul National University Hospital Seoul 03080 South Korea Details
Asan Medical Center Seoul 05505 South Korea Details
Gangnam Severance Hospital, Yonsei University Health System Seoul 06273 South Korea Details
Samsung Medical Center Seoul 06351 South Korea Details
Hospital Quiron de Madrid Pozuelo de Alarcón Madrid 28223 Spain Details
Hospital Universitario Virgen de La Arrixaca El Palmar Murcia 30120 Spain Details
National Taiwan Uni Hospital Taipei 100 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field